ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Xvivo Perfusion AB (PK)

Xvivo Perfusion AB (PK) (XVIPF)

40.00
0.00
(0.00%)
Closed January 18 3:00PM

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Key stats and details

Current Price
40.00
Bid
38.59
Ask
41.41
Volume
-
0.00 Day's Range 0.00
25.37 52 Week Range 52.3768
Market Cap
Previous Close
40.00
Open
-
Last Trade
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
333
Shares Outstanding
31,499,470
Dividend Yield
-
PE Ratio
36.36
Earnings Per Share (EPS)
2.92
Revenue
597.54M
Net Profit
91.82M

About Xvivo Perfusion AB (PK)

Sector
Surgical,med Instr,apparatus
Industry
Surgical,med Instr,apparatus
Headquarters
Goteborg, Swe
Founded
-
Xvivo Perfusion AB (PK) is listed in the Surgical,med Instr,apparatus sector of the OTCMarkets with ticker XVIPF. The last closing price for Xvivo Perfusion AB (PK) was US$40. Over the last year, Xvivo Perfusion AB (PK) shares have traded in a share price range of US$ 25.37 to US$ 52.3768.

Xvivo Perfusion AB (PK) currently has 31,499,470 shares outstanding. The market capitalization of Xvivo Perfusion AB (PK) is US$1.26 billion. Xvivo Perfusion AB (PK) has a price to earnings ratio (PE ratio) of 36.36.

XVIPF Latest News

No news to show yet.
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10040404020040CS
4-5.9-12.854030501145.945.94013342.625CS
12-5.17-11.445649767545.1745.94033342.42265566CS
26-7-14.89361702134752.37684032445.86835336CS
5212.243.884892086327.852.376825.3726541.04857245CS
15615.58563.833708785624.41552.376811.1527132.6666429CS
26024.5158.06451612915.552.376810.054129031.65555151CS

XVIPF - Frequently Asked Questions (FAQ)

What is the current Xvivo Perfusion AB (PK) share price?
The current share price of Xvivo Perfusion AB (PK) is US$ 40.00
How many Xvivo Perfusion AB (PK) shares are in issue?
Xvivo Perfusion AB (PK) has 31,499,470 shares in issue
What is the market cap of Xvivo Perfusion AB (PK)?
The market capitalisation of Xvivo Perfusion AB (PK) is USD 1.26B
What is the 1 year trading range for Xvivo Perfusion AB (PK) share price?
Xvivo Perfusion AB (PK) has traded in the range of US$ 25.37 to US$ 52.3768 during the past year
What is the PE ratio of Xvivo Perfusion AB (PK)?
The price to earnings ratio of Xvivo Perfusion AB (PK) is 36.36
What is the cash to sales ratio of Xvivo Perfusion AB (PK)?
The cash to sales ratio of Xvivo Perfusion AB (PK) is 5.59
What is the reporting currency for Xvivo Perfusion AB (PK)?
Xvivo Perfusion AB (PK) reports financial results in SEK
What is the latest annual turnover for Xvivo Perfusion AB (PK)?
The latest annual turnover of Xvivo Perfusion AB (PK) is SEK 597.54M
What is the latest annual profit for Xvivo Perfusion AB (PK)?
The latest annual profit of Xvivo Perfusion AB (PK) is SEK 91.82M
What is the registered address of Xvivo Perfusion AB (PK)?
The registered address for Xvivo Perfusion AB (PK) is MASSANS GATA 10, BOX 53015, GOTEBORG, SE-400 14
What is the Xvivo Perfusion AB (PK) website address?
The website address for Xvivo Perfusion AB (PK) is www.xvivoperfusion.com
Which industry sector does Xvivo Perfusion AB (PK) operate in?
Xvivo Perfusion AB (PK) operates in the SURGICAL,MED INSTR,APPARATUS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
TMGIMarquie Group Inc (PK)
US$ 0.0002
(19,900.00%)
4.03M
SEANSAEAN Group Inc (PK)
US$ 1.87
(18,600.00%)
100
BRGOBergio International Inc (PK)
US$ 0.0001
(9,900.00%)
540k
GMPRGourmet Provisions International Corporation (PK)
US$ 0.0001
(9,900.00%)
35.31M
PLPLPlandai Biotechnology Inc (PK)
US$ 0.0001
(9,900.00%)
18.06M
STNXStartronix International Inc (CE)
US$ 0.000001
(-99.99%)
450
AWINAERWINS Technologies Inc (CE)
US$ 0.000001
(-99.97%)
2.03k
ISOLImage Software Inc (CE)
US$ 0.000001
(-99.91%)
59.2k
NBIONascent Biotech Inc (CE)
US$ 0.0002
(-99.55%)
8.7k
FHBCFernhill Beverage Inc (CE)
US$ 0.000001
(-99.24%)
10k
GTCHGBT Technologies Inc (PK)
US$ 0.0001
(0.00%)
349.77M
VTXBVortex Brands Company (PK)
US$ 0.0002
(0.00%)
297.52M
EMEDElectroMedical Technologies Inc (PK)
US$ 0.0002
(0.00%)
233.53M
PHILPHI Group Inc (PK)
US$ 0.0002
(-33.33%)
184.12M
HMBLHUMBL Inc (PK)
US$ 0.0009
(-5.26%)
179.2M

Discussion

View Full Feed
rmoss rmoss 5 minutes ago
Moon you are always so negative on shib , but here you are still after a couple years I think. If you are making the money you claim you are you should be thankful and stay better things about this coin. But me thinks you full of s***. All my opinion of course.
SHIBUSD
samk samk 5 minutes ago
As soon as MARKET (MMs, funds, etc...) are ready and loaded, AVXL will make a big move up, all IMHO...
AVXL
yp_1 yp_1 6 minutes ago
7 years and they were not able to sell anything.
What is a probability of this to change?
SEV
dinogreeves dinogreeves 7 minutes ago
Very very interesting.
TGLO
Chartmaster Chartmaster 7 minutes ago
Welcome to Ihub, ur second day here! Now meet the ignore button! Bye!
AXXA
jog49 jog49 8 minutes ago
"Calabria got only 2 years after watt wasted 18 months of trump term. Then came otting for 6 months and then calabria for 2 years. This time Pulte has been nominated on day 1. He will get confirmed in next few months."

WATT . . . Much too long
OTTING . . . Much too short
FNMA
redspinelpinktopaz redspinelpinktopaz 8 minutes ago
Do the datacenters know what you know?
LWLG
wadegarret wadegarret 10 minutes ago
IART/GERN- Can't wait for the Q4 reports

I wish I knew if Q4 eps was going to be lowered. However as SS pointed out, when a company reiterates revenue guidance of a quarter that has passed, but no eps reiteration, one has to assume the worst for earnings. My feeling is, the quali
GERN
rayovac812 rayovac812 10 minutes ago
Missling should try an learn from Dale Carnegie's Sales Courses!

I would rather just read the data. Data doesn't lie or need sold. Some folks are financially motivated to strip the data of its meaning, but they can't strip the data of the fact that the biomarkers qualify and confi
AVXL
timberwolf7 timberwolf7 12 minutes ago
Its not 'speculative' anymore.

They PASSED 2 of the 3 clinical trials, met the end points
and the 3rd one they say only 'failed' reportedly only because folks withdrew from the trial, but
otherwise, again, reportedly met the trial end points.

Now its p
ATNM
werd werd 12 minutes ago
If MicroCloud Hologram Inc. (HOLO) is hiring up to 11 finance-related positions in China, this may reflect the following situations and strategic intentions:

Increased demand for finance and capital operations
• Capital market planning: Recruiting financiaL...

ht
HOLO
werd werd 12 minutes ago
If MicroCloud Hologram Inc. (HOLO) is hiring up to 11 finance-related positions in China, this may reflect the following situations and strategic intentions:

Increased demand for finance and capital operations
• Capital market planning: Recruiting financiaL...

ht
HOLO
williamssc williamssc 12 minutes ago
No mention of brain bleeds and death. Oh the irony
AVXL
MRc2 MRc2 13 minutes ago
$ILLR~ Triller app downloads on $AAPL app store ranking # 4 over night.
AAPL ILLR
crowin crowin 14 minutes ago
RDAR insiders appreciate any and ALL donations. They give themselves performance Bonuses for the hard work....LOL

On November 15, 2024, we issued a $200,000 principal amount convertible promissory note to Otus, LLC, a company owned by our Chief Financial Officer, Daniel Gilcher, at
RDAR
misterfishman misterfishman 14 minutes ago
true that,well my ravens better win on sunday night.
IGPK
dingodave dingodave 14 minutes ago
Striper where did you find this?
NLST
misterfishman misterfishman 15 minutes ago
naa i like black just like Bruce Wayne does.
IGPK
Slojab Slojab 16 minutes ago
I did it for people like you who can't seem to find anything on their own.

Hey, I can't find the EWR and the NR M, can you post them for me.

LoL
TWOH
WolfofMia WolfofMia 16 minutes ago
I don't know but I BET YOU ARE GOING TO TELL US!!!
AVXL
Stock_Barber Stock_Barber 17 minutes ago
Sometimes ignorance is intentional... TO DECEIVE OTHERS!

Sylvia, JJ, and other pumpers have been shown the FACTS/TRUTH hundreds of times, but choose to ignore it!

To call an actual chart "useless" and "clickbait" is proof beyond any doubt that we are either dealing with
DBMM
Armadillo49 Armadillo49 17 minutes ago
Like some others here, I’ve been waiting for quite a while for something to materialize. A few of my posts over the past few weeks have been a mix of both praise and condemnation of the company and management. Frustration finally got the best of me. Even though none of my comments were overly critic
CGAC
found_it2 found_it2 17 minutes ago
"Early blarcamesine use slows AD progression over 3 years"

Healio News
https://www.healio.com/news/neurology/20250113/early-blarcamesine-use-slows-ad-progression-over-3-years

Topline results from a phase 2b/3 clinical trial of blarcamesine for individuals with ea
AVXL
srinsocal srinsocal 17 minutes ago
When a prominent Orthopedic Surgeon uses and recommends RecoveryRx that is news

Don Buford, M.d.
Board Certified Orthopedic Surgeon
Specializes in Sports Medicine and Regenerative Medicine
Don Buford, MD founded Texas Orthobiologics as a clinic where patients can
BIEL

Your Recent History

Delayed Upgrade Clock